Capital Allocation Trends At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Aren't Ideal
Jun 20
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Drug Retail Industry Analysis
UpdatedJun 21, 2025
DataAggregated Company Financials
Companies4
- 7D1.4%
- 3M-26.1%
- 1Y-41.6%
- YTDn/a
In the last week, the Drug Retail industry is up 1.4%, with Raia Drogasil up 0.9%. In the past year, the industry is down 42%. Looking forward, earnings are forecast to grow by 19% annually.
Industry Valuation and Performance
Has the Brazilian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 22 Jun 2025 | R$27.7b | R$60.2b | R$1.3b | 17.1x | 20.7x | 0.5x |
| Tue, 20 May 2025 | R$28.9b | R$60.1b | R$1.3b | 17.5x | 21.6x | 0.5x |
| Thu, 17 Apr 2025 | R$40.0b | R$58.6b | R$1.3b | 21.4x | 30.1x | 0.7x |
| Sat, 15 Mar 2025 | R$36.2b | R$58.5b | R$1.5b | 13x | 24.9x | 0.6x |
| Mon, 10 Feb 2025 | R$37.8b | R$56.7b | R$1.4b | 11.4x | 26.9x | 0.7x |
| Wed, 08 Jan 2025 | R$41.0b | R$56.7b | R$1.4b | 12.4x | 29.2x | 0.7x |
| Fri, 06 Dec 2024 | R$45.6b | R$56.7b | R$1.4b | 12.6x | 32.5x | 0.8x |
| Sun, 03 Nov 2024 | R$45.2b | R$54.9b | R$1.3b | 16.7x | 35.9x | 0.8x |
| Tue, 01 Oct 2024 | R$47.1b | R$54.8b | R$1.3b | 16.2x | 37.5x | 0.9x |
| Thu, 29 Aug 2024 | R$51.3b | R$54.8b | R$1.3b | 18.3x | 40.9x | 0.9x |
| Sat, 27 Jul 2024 | R$49.7b | R$53.1b | R$1.2b | 30.1x | 41.1x | 0.9x |
| Mon, 24 Jun 2024 | R$47.4b | R$53.1b | R$1.2b | 28.4x | 39.2x | 0.9x |
| Wed, 22 May 2024 | R$51.0b | R$53.1b | R$1.2b | 20.2x | 40.8x | 1x |
| Fri, 19 Apr 2024 | R$46.2b | R$51.4b | R$1.2b | 29.4x | 39.5x | 0.9x |
| Sun, 17 Mar 2024 | R$49.9b | R$51.4b | R$1.2b | 31.5x | 42.7x | 1x |
| Tue, 13 Feb 2024 | R$47.1b | R$49.8b | R$1.1b | 20.4x | 44.5x | 0.9x |
| Thu, 11 Jan 2024 | R$54.0b | R$49.8b | R$1.1b | 22.1x | 51x | 1.1x |
| Sat, 09 Dec 2023 | R$52.4b | R$49.8b | R$1.1b | 20.9x | 49.5x | 1.1x |
| Mon, 06 Nov 2023 | R$46.9b | R$49.3b | R$997.0m | 20.1x | 47.1x | 1x |
| Wed, 04 Oct 2023 | R$50.2b | R$48.1b | R$948.8m | 20.2x | 52.9x | 1x |
| Fri, 01 Sep 2023 | R$51.3b | R$48.1b | R$948.8m | 22.1x | 54.1x | 1.1x |
| Sun, 30 Jul 2023 | R$53.9b | R$46.0b | R$1.1b | 23.3x | 50.8x | 1.2x |
| Tue, 27 Jun 2023 | R$53.3b | R$46.0b | R$1.1b | 22x | 50.2x | 1.2x |
| Thu, 25 May 2023 | R$51.5b | R$46.0b | R$1.1b | 20.3x | 48.5x | 1.1x |
| Sat, 22 Apr 2023 | R$45.1b | R$43.7b | R$1.1b | 16.9x | 41.3x | 1x |
| Mon, 20 Mar 2023 | R$42.2b | R$43.5b | R$1.1b | 16.5x | 38.6x | 1x |
| Wed, 15 Feb 2023 | R$41.2b | R$41.4b | R$1.0b | 30.2x | 40.7x | 1x |
| Fri, 13 Jan 2023 | R$43.3b | R$41.4b | R$1.0b | 31.4x | 42.8x | 1x |
| Sun, 11 Dec 2022 | R$42.2b | R$41.4b | R$1.0b | 30.8x | 41.8x | 1x |
| Tue, 08 Nov 2022 | R$48.5b | R$40.5b | R$1.1b | 22.1x | 43.7x | 1.2x |
| Thu, 06 Oct 2022 | R$44.0b | R$39.2b | R$1.0b | 21.9x | 41.9x | 1.1x |
| Sat, 03 Sep 2022 | R$41.5b | R$39.2b | R$1.0b | 20x | 39.6x | 1.1x |
| Mon, 01 Aug 2022 | R$38.4b | R$38.7b | R$1.0b | 31.3x | 36.7x | 1x |
| Wed, 29 Jun 2022 | R$36.1b | R$37.4b | R$945.0m | 31.6x | 38.2x | 1x |
Price to Earnings Ratio
38.2x
Current Industry PE
- Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 20.7x which is lower than its 3-year average PE of 40.2x.
- The industry is trading close to its 3-year average PS ratio of 0.94x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 12% per year over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Brazilian Drug Retail compare with similar industries?
| BR Market | -0.049% | |
| Consumer Staples | -0.90% | |
| Food and Staples Retail | 0.14% | |
| Drug Retail | 1.36% | |
| Food Retail | 0% | 0 |
| Big Box Super Stores | -0.89% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RADL3 Raia Drogasil | R$14.00 | 0.9% +R$205.6m | -45.7% | PE20.4x | |
| PNVL3 Dimed Distribuidora de Medicamentos | R$8.96 | 9.5% +R$116.2m | -7.4% | PE13.7x | |
| PGMN3 Empreendimentos Pague Menos | R$3.43 | 2.7% +R$55.7m | 49.1% | PE50.6x |
